Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Conversant Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Conversant Bio

Conversant Bio

Conversant Bio provides high-quality tissue samples from a vast US network to global researchers for disease investigation.

HQ
Huntsville, AL, US
Founded
2006
Overview
Compare
Fundraising
Employees

Conversant Bio's mission is to supply high-quality tissue samples to researchers worldwide, enabling advanced investigations into critical diseases. With a network of over 50 U.S.-based clinical sites and a rigorous IRB-reviewed Quality Control System, the company ensures timely and budget-conscious delivery of samples.

Conversant Bio has significantly impacted medical research by providing essential resources for cutting-edge studies. Their commitment to quality and reliability has made them a trusted partner in the scientific community, advancing the understanding and treatment of various diseases.

Conversant Bio - Similar Companies

iSpecimen logo

iSpecimen

ispecimen.com

AnaBios logo

AnaBios

anabios.com

Sanguine logo

Sanguine

sanguinebio.com

TriMetis Life Sciences logo

TriMetis Life Sciences

Humabiologics logo

Humabiologics

humabiologics.com

First Choice Bio logo

First Choice Bio

firstchoicebio.com

Convoy Therapeutics logo

Convoy Therapeutics

BioAnalytics logo

BioAnalytics

BioSurfaces logo

BioSurfaces

biosurfaces.us

Transomic Technologies logo

Transomic Technologies

Global Registry of Biorepositories logo

Global Registry of Biorepositories

Vivebio logo

Vivebio

InVivo Biosystems logo

InVivo Biosystems

BiomedInnovations logo

BiomedInnovations

Ibex Biosciences logo

Ibex Biosciences

ibex.bio

Conversant Bio - Quick Facts

Who are Conversant Bio's competitors?

Companies similar to Conversant Bio include iSpecimen, AnaBios, Sanguine and TriMetis Life Sciences.

When was Conversant Bio founded?

Conversant Bio was founded in 2006.

Where is Conversant Bio's headquarters located?

Conversant Bio's headquarters is located in Huntsville, AL, US.

When was Conversant Bio's last funding round?

Conversant Bio's most recent funding round was for $50k (USD) in March 2015.

How much has Conversant Bio raised to-date?

As of Mar 24, 2015, Conversant Bio has raised a total of $50k (USD).

How many employees does Conversant Bio have?

Conversant Bio has 125 employees as of Feb 4, 2024.

Conversant Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Tissue Samples
Tags
  • API
  • Data Information
  • Research
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified